

At Boehringer Ingelheim we are committed to providing our customers with innovative medicines to improve their health and quality of life. We strongly believe in creating value through innovation and are constantly looking for new ways to improve the well-being of our customers around the world.
The purpose of this information is educational. Boehringer Ingelheim encourages consumers to seek further information from an appropriate healthcare professional.
We focus on researching and developing new drugs and treatments that represent major therapeutic advances. We are a proven leader in respiratory healthcare. Additionally, recent research has resulted in the development of treatments for a diverse range of medical conditions.
Today we offer therapeutic options for diseases and conditions such as chronic obstructive pulmonary disease (COPD), high blood pressure, stroke, Parkinson's disease, HIV/AIDS, arthritis, thrombosis and complications of blood clotting, restless leg syndrome (RLS) and continue our extensive research in cancer, virology, stroke prevention, diabetes and respiratory diseases.
Learn about different therapeutic areas including acute myocardial infarction, arthritis, chronic obstructive pulmonary disease, HIV/AIDS, hypertension, Parkinson's disease, restless legs syndrome, stroke and venous thromboembolism.
The information about our prescription medicine products on this page is intended only for residents of Australia.
The information about our prescription medicine products on this page is intended only for residents of New Zealand.
Supporting the Quality Use of Medicines
Our company is committed to promoting the
Quality Use of Medicines, ensuring that our medicines conform to the highest standards of safety, efficacy and quality; are supported by comprehensive technical and information services; are professional in dealing with healthcare professionals, public health officials and consumers; and promote the quality use of medicines and principles within the Australian National Strategy for Quality Use of Medicines.